Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Memantine Derivatives as Multitarget Agents in Alzheimer’s Disease
Giambattista Marotta, Filippo Basagni, Michela Rosini, et al.
Molecules (2020) Vol. 25, Iss. 17, pp. 4005-4005
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Basic information about memantine and its treatment of Alzheimer's disease and other clinical applications
Bin‐Can Tang, Ya‐Ting Wang, Jie Ren
Ibrain (2023) Vol. 9, Iss. 3, pp. 340-348
Open Access | Times Cited: 39
Memantine: Updating a rare success story in pro-cognitive therapeutics
Parisa Karimi Tari, Chris G. Parsons, Graham L. Collingridge, et al.
Neuropharmacology (2023) Vol. 244, pp. 109737-109737
Open Access | Times Cited: 28
Phytochemicals as inhibitors of tumor necrosis factor alpha and neuroinflammatory responses in neurodegenerative diseases
Amirhossein Sahebkar, Fatemeh Zahedipour, SeyedeAtefe Hosseini, et al.
Neural Regeneration Research (2021) Vol. 17, Iss. 8, pp. 1675-1675
Open Access | Times Cited: 42
Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis
Anna Sampietro, F. Javier Pérez-Areales, Paula Felippe Martinez, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 545-545
Open Access | Times Cited: 32
Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches
Amirreza Gholami
Neuroscience Letters (2023) Vol. 817, pp. 137532-137532
Closed Access | Times Cited: 22
Cholinesterase inhibitors and memantine for the treatment of Alzheimer and non-Alzheimer dementias
Nóra Balázs, Dániel Bereczki, Tibor Kovács
Ideggyógyászati Szemle (2021) Vol. 74, Iss. 11-12, pp. 379-387
Open Access | Times Cited: 35
Multipharmacophore strategy in medicinal chemistry for the design of drugs for the treatment of Alzheimer’s and some other neurodegenerative diseases
С. О. Бачурин, А. Yu. Aksinenko, Галина Ф. Махаева, et al.
Russian Chemical Bulletin (2023) Vol. 72, Iss. 1, pp. 130-147
Closed Access | Times Cited: 16
Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, et al.
Molecules (2024) Vol. 29, Iss. 21, pp. 5131-5131
Open Access | Times Cited: 5
Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer’s disease
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
Future Perspectives of NMDAR in CNS Disorders
Toni Capó, Joan Biel Rebassa, Iu Raïch, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 877-877
Open Access
Improving executive functioning and reducing the risk of Alzheimer's disease with music therapy: A narrative review of potential neural mechanisms
Benjamin Slade, Benedict J Williams, Romy Engelbrecht, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Antiglycoxidative properties of amantadine – a systematic review and comprehensive in vitro study
Miłosz Nesterowicz, Małgorzata Żendzian‐Piotrowska, Jerzy Robert Ładny, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 138-155
Open Access | Times Cited: 13
Structure-activity relationships of dually-acting acetylcholinesterase inhibitors derived from tacrine on N-methyl-d-Aspartate receptors
Lukáš Górecki, Anna Misiachna, Jir̆ı́ Damborský, et al.
European Journal of Medicinal Chemistry (2021) Vol. 219, pp. 113434-113434
Open Access | Times Cited: 17
Calcium Modulating Effect of Polycyclic Cages: A Suitable Therapeutic Approach Against Excitotoxic-induced Neurodegeneration
Ayodeji O. Egunlusi, Sarel F. Malan, Vitalii A. Palchykov, et al.
Mini-Reviews in Medicinal Chemistry (2024) Vol. 24, Iss. 13, pp. 1277-1292
Closed Access | Times Cited: 2
Phytotherapy in Alzheimer’s Disease—A Narrative Review
Julia Piekarz, Natalia Picheta, Oliwia Burdan, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1812-1812
Open Access | Times Cited: 2
Synthesis and biological evaluation of selective histone deacetylase 6 inhibitors as multifunctional agents against Alzheimer's disease
Xiuxiu Wang, Fei Xie, Congcong Jia, et al.
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113821-113821
Closed Access | Times Cited: 14
Constituents of Stachys plants as potential dual inhibitors of AChE and NMDAR for the treatment of Alzheimer’s disease: a molecular docking and dynamic simulation study
Iman Touati, Mohnad Abdalla, Naif H. Ali, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 5, pp. 2586-2602
Closed Access | Times Cited: 5
Prodrug Therapies for Infectious and Neurodegenerative Diseases
Milica Marković, Suyash Deodhar, Jatin Machhi, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 518-518
Open Access | Times Cited: 8
Synthesis of conjugates of 5-methyl-2-phenylpyrazol-3-ones and 1-aminoadamantanes as potential neuroprotective agents
А. Yu. Aksinenko, Т. В. Горева, Т. А. Епишина, et al.
Russian Chemical Bulletin (2022) Vol. 71, Iss. 8, pp. 1794-1800
Closed Access | Times Cited: 8
Novel Multitarget Hydroxamic Acids with a Natural Origin CAP Group against Alzheimer’s Disease: Synthesis, Docking and Biological Evaluation
Маргарита Е. Неганова, Yulia Aleksandrova, Е. В. Суслов, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1893-1893
Open Access | Times Cited: 11
Molecular insights into P2X signalling cascades in acute kidney injury
Swati Mishra, Vishwadeep Shelke, Neha Dagar, et al.
Purinergic Signalling (2024) Vol. 20, Iss. 5, pp. 477-486
Open Access | Times Cited: 1
Unlocking Neurodegeneration: Scaffold-Derived Blockers of MAO-B and AChE inspired by Bryophyllum pinnatum: A Structural Exploration
Ezekiel A. Olugbogi, Emmanuel Sunday Omirin, Shola D. Omoseeye, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Therapeutic Options in Alzheimer’s Disease: From Classic Acetylcholinesterase Inhibitors to Multi-Target Drugs with Pleiotropic Activity
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1555-1555
Open Access | Times Cited: 1
Memantine-Derived Schiff Bases as Transdermal Prodrug Candidates
Ana P. A. Oliveira, Victoria C. Romero Colmenares, Renata Diniz, et al.
ACS Omega (2022) Vol. 7, Iss. 14, pp. 11678-11687
Open Access | Times Cited: 7
Unfavorable effects of memantine on the skeletal system in female rats
Piotr Londzin, Urszula Cegieła, Marcin Trawczyński, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114921-114921
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top